MRK - Company ID 0000310158
Merck & Co., Inc. (MRK) reported net income of $18.25B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $18.25B | +6.6% |
| FY 2024 | $17.12B | +4589.6% |
| FY 2023 | $365.00M | -97.5% |
| FY 2022 | $14.52B | +17.6% |
| FY 2021 | $12.35B | +74.7% |
| FY 2020 | $7.07B | -28.2% |
| FY 2019 | $9.84B | +58.2% |
| FY 2018 | $6.22B | +159.8% |
| FY 2017 |
Merck & Co., Inc. (MRK) reported net income of $18.25B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Merck & Co., Inc.'s net income grew from $6.27B to $18.25B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.39B |
| -38.9% |
| FY 2016 | $3.92B | -11.8% |
| FY 2015 | $4.44B | -62.7% |
| FY 2014 | $11.92B | +170.7% |
| FY 2013 | $4.40B | -28.6% |
| FY 2012 | $6.17B | -1.7% |
| FY 2011 | $6.27B | - |